» Articles » PMID: 39630315

Involvement of Necroptosıs and Apoptosıs ın Protectıve Effects of Cyclosporın a on Ischemıa-reperfusıon Injury in Rat Kıdney

Overview
Journal J Mol Histol
Specialty Biochemistry
Date 2024 Dec 4
PMID 39630315
Authors
Affiliations
Soon will be listed here.
Abstract

We aimed to investigate the protective effects of low dose cyclosporin A (CsA) on ischemia-reperfusion (IR) injury in rat the kidney and on the apoptotic and necroptotic mechanisms involved. 1. Control group (received a single intraperitoneal (i.p.) dose of 1 ml sterile saline 15 min before the surgical procedure), 2. IR group (was subjected to 30 min of bilateral kidney ischemia followed by 90 min of reperfusion; and received a single i.p. dose of 1 ml sterile saline 15 min before the IR procedure, 3. IR + CsA group (received a single i.p. dose of 3 mg/kg CsA 15 min before the IR procedure. Renal functions (renal perfusion pressures, and serum urea-creatinine levels), kidney histological scores, MDA levels, and TNF-α, caspase-3, RIP1, RIP3, MLKL, CaMKII and CypD protein expressions were also measured. Renal perfusion pressures (PP), serum urea and creatinine levels, renal tissue MDA levels, and the protein expression levels of TNF-α, caspase-3, RIP1, RIP3, MLKL, CAMKII and CypD were significantly increased in the IR group compared to the control group (p < 0.05), Additionally, there were significant decreases in all the parameters in the IR + CsA group compared to those in the IR group (p < 0.05). Furthermore, histopathological analyses revealed significantly higher kidney injury scores in the IR group compared to the control group, and low dose CsA treatment improved the injury. A single low dose of CsA injection 15 min before IR, demonstrated a protective effect on bilateral renal IR injury and a reduction in apoptotic and necroptopic markers which is resulted in improvement of renal functions.

References
1.
Bertheloot D, Latz E, Franklin B . Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021; 18(5):1106-1121. PMC: 8008022. DOI: 10.1038/s41423-020-00630-3. View

2.
Bonventre J, Yang L . Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest. 2011; 121(11):4210-21. PMC: 3204829. DOI: 10.1172/JCI45161. View

3.
Chen K, Chai H, Chen C, Huang C, Chiang J, Sung P . Synergic effect of combined cyclosporin and melatonin protects the brain against acute ischemic reperfusion injury. Biomed Pharmacother. 2021; 136:111266. DOI: 10.1016/j.biopha.2021.111266. View

4.
Choi M, Price D, Ryter S, Choi A . Necroptosis: a crucial pathogenic mediator of human disease. JCI Insight. 2019; 4(15). PMC: 6693822. DOI: 10.1172/jci.insight.128834. View

5.
Creamer T . Calcineurin. Cell Commun Signal. 2020; 18(1):137. PMC: 7456046. DOI: 10.1186/s12964-020-00636-4. View